January 3, 2013

Dr. Reddy's Labs has launched a generic drug for treating baldness, the Indian drug maker said.

January 3, 2013

An experimental drug for Lou Gehrig's disease made by Biogen Idec has failed in a late-stage clinical trial, the drug maker said.

January 3, 2013

The Food and Drug Administration has approved a generic drug for heavy menstrual bleeding made by Watson Pharmaceuticals, the drug maker said.

January 3, 2013

Fred's reported a 1% sales decline to $209.9 million for the five-week fiscal month ended Dec. 29.

January 3, 2013

Pfizer's generics division has launched an authorized generic drug for treating epilepsy.

January 3, 2013

H-E-B announced that it is introducing more ways to help customers eat and live healthier in 2013, including the introduction of a nutrition labeling system and a weekly newsletter filled with healthy tips, recipes and coupons.

January 3, 2013

People making New Year's resolutions, mostly centered around health, this year say they behave more responsibly than they did five years ago compared with those not making them, according to a new survey.

January 3, 2013

Murad has announced the launch of Rapid Collagen Infusion, a multi-tasking formula that is designed to fight wrinkles and loss of resilience by promoting collagen and elastin production while maintaining healthy hydration levels in the skin.

January 3, 2013

Reaching out to discharged hospital patients by telephone could help reduce the chances they'll be readmitted in the future, according to a new study by a healthcare service company.

January 3, 2013

Par Pharmaceutical Cos. has started shipping two formulations of a generic drug for treating migraines, the company said.

January 3, 2013

Pepperidge Farm, makers of popular Milano cookies and Goldfish snack crackers, has unveiled new Jingos! snack crackers.

January 3, 2013

A court has ruled in favor of Indian generic drug maker Ranbaxy Labs in a case concerning a generic blood pressure drug, the legal firm representing the drug maker said.

January 3, 2013

A shift in the New Year's holiday calendar and the introduction of new generic drugs contributed to a decrease in same-store sales for the month of December at Rite Aid, the retail pharmacy chain said.

January 3, 2013

Safeway late Wednesday announced that Steve Burd, its long-time chairman and CEO, will retire at the company's annual stockholders meeting on May 14, 2013.

January 3, 2013

Weaker than expected December sales at Target will cause fourth quarter profits to come in at the low end of an earlier forecast, the company said.

January 3, 2013

An inhaler for patients with bronchospasm that includes a dose counter has become available from Teva Respiratory, the company said Thursday.

January 2, 2013

Consumers who purchased Chattem’s ACT Total Care Anticavity Fluoride Mouthwash between Jan. 1, 2009, and June 30, 2010, may be entitled to a cash refund from a class action settlement, according to a statement issued by the manufacturer.

January 2, 2013

DevaCurl — a hair care brand designed exclusively for curly, wavy and chemically processed hair — has created the DevaCurl No-Comb Detangling Spray to untangle, fortify and revitalize dry, damaged and frizz-prone curls while restoring moisture balance.

January 2, 2013

The retailer has grown steadily according to president and CEO Bob Sasser, leading the company to expand its Marietta, Okla. distribution center.

January 2, 2013

In 2012, the Food and Drug Administration approved 39 new drugs, 8 alone in December, marking the largest increase in 16 years.

January 2, 2013

The Food and Drug Administration last week approved the anti-clotting drug Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots in patients with atrial fibrillation that is not caused by a heart valve problem. Eliquis is manufactured by Bristol-Myers Squibb, and marketed by BMS and Pfizer.

January 2, 2013

The U.S. Food and Drug Administration has approved a new drug from Johnson & Johnson for patients with tuberculosis who do not respond to other treatments, the company announced.

January 2, 2013

Mylan announced that its subsidiary, Mylan Pharmaceuticals, has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug applications for rizatriptan benzoate orally disintegrating tablets and rizatriptan benzoate tablets, generic versions of Merck's Maxalt MLT Tablets and Maxalt Tablets.

January 2, 2013

The U.S. Food and Drug Administration on Monday approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral therapy, a combination of medicines used to treat HIV infection.